Development of Recifercept, a FGFR3 decoy protein, as a potential treatment for Achondroplasia

被引:0
|
作者
Czech, Christian
Slade, Alison
Goncalves, Diogo
Roberts, Kevin
Dawra, Vikas Kumar
Rignol, Guylene
机构
[1] Pfizer, Paris, France
[2] Pfizer, Zurich, Switzerland
[3] Pfizer, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT-647
引用
收藏
页码:170 / 170
页数:1
相关论文
共 50 条
  • [1] Fate of FGFR3 in achondroplasia
    Horton, William A.
    Lunstrum, Gregory P.
    Degnin, Catherine R.
    Laederich, Melanie B.
    ENDOCRINE JOURNAL, 2010, 57 : S247 - S247
  • [2] Targeting an Fgfr3 Enhancer as a Potential Therapeutic Tool for Achondroplasia
    Angelozzi, Marco
    Molin, Arnaud
    Karvande, Anirudha
    Fernandez-Iglesias, Angela
    Haseeb, Abdul
    Whipple, Samantha
    Lefebvre, Veronique
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 28 - 29
  • [3] FGFR3 targeting strategies for achondroplasia
    Laederich, Melanie B.
    Horton, William A.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2012, 14
  • [4] Recifercept, a soluble recombinant FGFR3 for the treatment of achondroplasia, is safe and well-tolerated after single and multiple dose administration in healthy volunteers
    Wajnrajch, Michael
    Greig, Gerard
    Meyer, Christian
    Dawra, Vikas Kumar
    Cara, Jose
    Czech, Christian
    Collins, Samuel
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 168 - 168
  • [5] Quantification of lateral associations of achondroplasia in FGFR3
    McKenzie, Daniel M.
    Hristova, Kalina
    Roy, Tanaya
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 196A - 196A
  • [6] Number and brightness studies of the FGFR3 achondroplasia mutant
    Roy, Tanaya
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 56A - 56A
  • [7] Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia
    Lorget, Florence
    Kaci, Nabil
    Peng, Jeff
    Benoist-Lasselin, Catherine
    Mugniery, Emilie
    Oppeneer, Todd
    Wendt, Dan J.
    Bell, Sean M.
    Bullens, Sherry
    Bunting, Stuart
    Tsuruda, Laurie S.
    O'Neill, Charles A.
    Di Rocco, Federico
    Munnich, Arnold
    Legeai-Mallet, Laurence
    AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (06) : 1108 - 1114
  • [8] Bone: FGFR3 mutation delays bone age in achondroplasia
    Koch L.
    Nature Reviews Endocrinology, 2010, 6 (11) : 596 - 596
  • [9] Achondroplasia phenotype due to novel FGFR3 mutation.
    Zabel, BU
    Hilbert, K
    Beck, M
    Stelzer, C
    Wildhardt, G
    Winterpacht, A
    Spranger, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 388 - 388
  • [10] FGFR3 mutation causes abnormal membranous ossification in achondroplasia
    Di Rocco, Federico
    Duplan, Martin Biosse
    Heuze, Yann
    Kaci, Nabil
    Komla-Ebri, Davide
    Munnich, Arnold
    Mugniery, Emilie
    Benoist-Lasselin, Catherine
    Legeai-Mallet, Laurence
    HUMAN MOLECULAR GENETICS, 2014, 23 (11) : 2914 - 2925